The thirteenth biennial meeting on Mechanisms & Models of Cancer is going fully virtual and will begin late morning EST on Tuesday August 11 and end late afternoon EST on Friday August 14, 2020. Oral sessions will be confined to later morning and afternoon sessions EST to maximize access by participants from around the world. An outline program will be posted following further discussion with the organizers.
The specific goal of this conference is to bring together a diverse group of scientists studying various molecular, genetic, biochemical and animal model approaches to the analysis of cancer. Junior and senior researchers will join to discuss their latest research findings and technical approaches toward the analysis of cancer models and mechanisms.
The format of the meeting will include morning and afternoon virtual sessions consisting of eight or nine 15-minute talks per session, selected from the abstracts, principally on unpublished work. In addition, there will be two poster sessions. The organizers will decide the suitability of each abstract for oral or poster presentation, but please specify if you prefer a poster.
- Experimental Therapeutics
- Stem Cells, Self-Renewal and Cancer
- Genomics, Heterogeneity and Cancer Evolution
- Cancer Metabolism
- The Cancer Epigenome
- Proliferation and Survival Signaling
- Tumor Immunology and Immunotherapy
- Tumor-Host Interactions and Metastasis
Keynote Speakers (to be reconfirmed):
Robert Schreiber, Washington University School of Medicine
Eileen White, The Rutgers Cancer Institute of New Jersey
Session Chairs (to be reconfirmed)
E. Elizabeth Patton, The University of Edinburgh
Alana Welm, University of Utah School of Medicine
Stem Cells, Self-Renewal and Cancer
Omar Abdel-Wahab, Memorial Sloan Kettering Cancer Center
Genomics, Heterogeneity and Cancer Evolution
Margaret Goodell, Baylor College of Medicine
Sohrab Shah, Memorial Sloan Kettering Cancer Center
Ralph DeBerardinis, UT Southwestern Children's Medical Center
Marcia Haigis, Harvard Medical School
The Cancer Epigenome
Brad Cairns, University of Utah, Huntsman Cancer Institute
Cigall Kadoch, Dana-Farber Cancer Institute/HMS
Proliferation and Survival Signaling
Anthony Letai, Dana-Farber Cancer Institute
Laura Soucek, Vall d´Hebron Institute of Oncology (VHIO), Spain
Tumor Immunology and Immunotherapy
Andrea Schietinger, Memorial Sloan Kettering Cancer Center
Stefani Spranger, MIT
Tumor-Host Interactions and Metastasis
Alec Kimmelman, NYU School of Medicine
Partial support provided by National Cancer Institute
Please bring this notice to the attention of any of your colleagues who may be interested in participating in the meeting.
All abstracts must be submitted by the abstract deadline. Late registrations may be accepted after the abstract deadline if the meeting is not oversubscribed. The status (talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers.
All questions pertaining to the virtual conference should be directed to Catie Carr at firstname.lastname@example.org.
We have applied for funds from government and industry to partially support graduate students and postdocs. Please apply in writing via email to Catie Carr at email@example.com and state your financial needs; preference will be given to those who submit abstracts.